Beta-1-adrenergic receptors mediate Nrf2-HO-1-HMGB1 axis regulation to attenuate hypoxia/reoxygenation-induced cardiomyocytes injury in vitro

Cellular Physiology and Biochemistry

Volumn 35, Issue 2, 2015, Pages 767-777

  Wang, Jichun ^a   Hu, Xiaorong ^a   Xie, Jing ^a   Xu, Weipan ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Heme oxygenase 1; High mobility group box 1 protein; Nuclear factor erythroid 2 related factor 2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BETA 1 ADRENERGIC RECEPTOR; DOBUTAMINE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; LACTATE DEHYDROGENASE; MALONALDEHYDE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TREATMENT FAILURE; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART MUSCLE CELL; HEART PROTECTION; HYPOXIA; IN VITRO STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; REOXYGENATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

RATTUS;

EID: 84964289066     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369736     Document Type: Article

References (34)

1. Zhou X, Luo YC, Ji WJ, Zhang L, Dong Y, Ge L, Lu RY, Sun HY, Guo ZZ, Yang GH, Jiang TM, Li YM: Modulation of mononuclear phagocyte inflammatory response by liposome-encapsulated voltage gated sodium channel inhibitor ameliorates myocardial ischemia/reperfusion injury in rats. PLoS One 2013; 8: e74390.
2. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U: Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 2011; 123: 594-604.
3. Li J, Zhang H, Zhang C: Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: Mechanisms and therapeutic implications. J Mol Cell Cardiol 2012; 52: 865-872.
4. Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbaurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A: High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 2008; 117: 3216-3226.
5. Hu X, Jiang H, Bai Q, Zhou X, Xu C, Lu Z, Cui B, Wen H: Increased serum hmgb1 is related to the severity of coronary artery stenosis. Clin Chim Acta 2009; 406: 139-142.
6. Hu X, Fu W, Jiang H: Hmgb1: A potential therapeutic target for myocardial ischemia and reperfusion injury. Int J Cardiol 2012; 155: 489.
7. Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: Unleashing the protective properties of heme. Trends Immunol 2003; 24: 449-455.
8. Hwa JS, Jin YC, Lee YS, Ko YS, Kim YM, Shi LY, Kim HJ, Lee JH, Ngoc TM, Bae KH, Kim YS, Chang KC: 2-methoxycinnamaldehyde from cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to ho-1 induction. J Ethnopharmacol 2012; 139: 605-615.
9. Ha YM, Ham SA, Kim YM, Lee YS, Kim HJ, Seo HG, Lee JH, Park MK, Chang KC: Beta (1)-adrenergic receptor-mediated ho-1 induction, via pi3k and p38 mapk, by isoproterenol in raw 264.7 cells leads to inhibition of hmgb1 release in lps-activated raw 264.7 cells and increases in survival rate of clp-induced septic mice. Biochem Pharmacol 2011; 82: 769-777.
10. Salie R, Moolman JA, Lochner A: The role of beta-adrenergic receptors in the cardioprotective effects of beta-preconditioning (betapc). Cardiovasc Drugs Ther 2011; 25: 31-46.
11. Wang J, Yang H, Hu X, Fu W, Xie J, Zhou X, Xu W, Jiang H: Dobutamine-mediated heme oxygenase-1 induction via pi3k and p38 mapk inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia/reperfusion injury in vivo. J Surg Res 2013; 183: 509-516.
12. Yan L, Tang Q, Shen D, Peng S, Zheng Q, Guo H, Jiang M, Deng W: Socs-1 inhibits tnf-alpha-induced cardiomyocyte apoptosis via erk1/2 pathway activation. Inflammation 2008; 31: 180-188.
13. Hu X, Zhou X, He B, Xu C, Wu L, Cui B, Wen H, Lu Z, Jiang H: Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol 2010; 638: 84-89.
14. Alfieri A, Srivastava S, Siow RC, Modo M, Fraser PA, Mann GE: Targeting the nrf2-keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol 2011; 589: 4125-4136.
15. Kanninen K, White AR, Koistinaho J, Malm T: Targeting glycogen synthase kinase-3beta for therapeutic benefit against oxidative stress in alzheimer's disease: Involvement of the nrf2-are pathway. Int J Alzheimers Dis 2011; 2011: 985085.
16. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, Porter AG, O'Farrelly C, Rabb H, Taylor CT: Reoxygenation-specific activation of the antioxidant transcription factor nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. Faseb J 2006; 20: 2624-2626.
17. Sagai M, Bocci V: Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Med Gas Res 2011; 1: 29.
18. Eom HW, Park SY, Kim YH, Seong SJ, Jin ML, Ryu EY, Kim MJ, Lee SJ: Bambusae caulis in taeniam modulates neuroprotective and anti-neuroinflammatory effects in hippocampal and microglial cells via ho-1-and nrf-2-mediated pathways. Int J Mol Med 2012; 30: 1512-1520.
19. Jin GH, Park SY, Kim E, Ryu EY, Kim YH, Park G, Lee SJ: Anti-inflammatory activity of bambusae caulis in taeniam through heme oxygenase-1 expression via nrf-2 and p38 mapk signaling in macrophages. Environ Toxicol Pharmacol 2012; 34: 315-323.
20. Senthil Kumar KJ, Liao JW, Xiao JH, Gokila Vani M, Wang SY: Hepatoprotective effect of lucidone against alcohol-induced oxidative stress in human hepatic hepg2 cells through the up-regulation of ho-1/nrf-2 antioxidant genes. Toxicol In Vitro 2012; 26: 700-708.
21. Ryu EY, Park AJ, Park SY, Park SH, Eom HW, Kim YH, Park G, Lee SJ: Inhibitory effects of ginkgo biloba extract on inflammatory mediator production by porphyromonas gingivalis lipopolysaccharide in murine macrophages via nrf-2 mediated heme oxygenase-1 signaling pathways. Inflammation 2012; 35: 1477-1486.
22. Farmer P, Pugin J: Beta-adrenergic agonists exert their "Anti-inflammatory" Effects in monocytic cells through the ikappab/nf-kappab pathway. Am J Physiol Lung Cell Mol Physiol 2000; 279: L675-682.
23. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S: Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010; 80: 1895-1903.
24. Park MK, Kang YJ, Ha YM, Jeong JJ, Kim HJ, Seo HG, Lee JH, Chang KC: Ep2 receptor activation by prostaglandin e2 leads to induction of ho-1 via pka and pi3k pathways in c6 cells. Biochem Biophys Res Commun 2009; 379: 1043-1047.
25. Kusunoki C, Yang L, Yoshizaki T, Nakagawa F, Ishikado A, Kondo M, Morino K, Sekine O, Ugi S, Nishio Y, Kashiwagi A, Maegawa H: Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the nrf-2/ho-1 pathway in 3t3-l1 adipocytes. Biochem Biophys Res Commun 2013; 430: 225-230.
26. Zhang DW, Bian ZP, Xu JD, Wu HF, Gu CR, Zhou B, Chen XJ, Yang D: Astragaloside iv alleviates hypoxia/ reoxygenation-induced neonatal rat cardiomyocyte injury via the protein kinase a pathway. Pharmacology 2012; 90: 95-101.
27. Xu XL, Chen XJ, Ji H, Li P, Bian YY, Yang D, Xu JD, Bian ZP, Zhang JN: Astragaloside iv improved intracellular calcium handling in hypoxia-reoxygenated cardiomyocytes via the sarcoplasmic reticulum ca-atpase. Pharmacology 2008; 81: 325-332.
28. Zheng YQ, Wei W: Total glucosides of paeony suppresses adjuvant arthritis in rats and intervenes cytokine-signaling between different types of synoviocytes. Int Immunopharmacol 2005; 5: 1560-1573.
29. Xiao JF, Wang CY, Huang YP, Shen JX, Gao FF, Huang ZQ, Zheng YS, Shi GG: N-n-butyl haloperidol iodide preserves cardiomyocyte calcium homeostasis during hypoxia/ischemia. Cell Physiol Biochem 2011; 27: 433-442.
30. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004; 101: 296-301.
31. Takamiya R, Hung CC, Hall SR, Fukunaga K, Nagaishi T, Maeno T, Owen C, Macias AA, Fredenburgh LE, Ishizaka A, Blumberg RS, Baron RM, Perrella MA: High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient mice. Am J Respir Cell Mol Biol 2009; 41: 129-135.
32. Tsoyi K, Lee TY, Lee YS, Kim HJ, Seo HG, Lee JH, Chang KC: Heme-oxygenase-1 induction and carbon monoxide-releasing molecule inhibit lipopolysaccharide (lps)-induced high-mobility group box 1 release in vitro and improve survival of mice in lps-and cecal ligation and puncture-induced sepsis model in vivo. Mol Pharmacol 2009; 76: 173-182.
33. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Metz C, Miller EJ, Tracey KJ, Ulloa L: Cholinergic agonists inhibit hmgb1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221.
34. Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN: Activation of nrf2-antioxidant signaling attenuates nfkappab-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008; 76: 1485-1489.